Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses

Yevgeniy Y. Studentsov, Gloria Y F Ho, Morgan A. Marks, Robert Bierman, Robert D. Burk

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Human papillomavirus type 16 (HPV16) virus-like particles (VLP) were used as antigen in a polymer enzyme-linked immunosorbent assay (ELISA) to measure antibodies to HPV capsid proteins. Serum samples from 575 college women, previously tested for the presence of cervicovaginal HPV DNA, were analyzed. The prevalences of anti-HPV16 VLP antibodies at baseline were 14.1% for immunoglobulin G (IgG) and 6.4% for IgA. The seroprevalences of IgG in women with cervicovaginal HPV16, HPV16-related types, and other HPV types were 55, 33, and 19%, respectively (P < 0.001), compared to the prevalence in women without an HPV infection (10%). HPV VLP IgA seropositivity was associated with high HPV16 VLP IgG optical density values. The seropositivity of IgG antibodies was independently associated with infection with HPV16 or HPV16-related types, increased number of lifetime male partners for vaginal sex, having sex with men ≥5 years older, history of abnormal PAP smear, older age, and living separately from parents. Use of HPV16 VLP polymer ELISA detects clade-specific responses and suggests an HPV16 VLP vaccine may have broader protection that initially anticipated.

Original languageEnglish (US)
Pages (from-to)2827-2834
Number of pages8
JournalJournal of Clinical Microbiology
Volume41
Issue number7
DOIs
StatePublished - Jul 1 2003

Fingerprint

Papillomaviridae
Human papillomavirus 16
Virion
Polymers
Enzyme-Linked Immunosorbent Assay
Immunoglobulin G
Immunoglobulin A
Antibodies
Virus-Like Particle Vaccines
Seroepidemiologic Studies
Capsid Proteins
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses. / Studentsov, Yevgeniy Y.; Ho, Gloria Y F; Marks, Morgan A.; Bierman, Robert; Burk, Robert D.

In: Journal of Clinical Microbiology, Vol. 41, No. 7, 01.07.2003, p. 2827-2834.

Research output: Contribution to journalArticle

@article{4f60326b122c4b8dadbcbb8bd7b5a7a7,
title = "Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses",
abstract = "Human papillomavirus type 16 (HPV16) virus-like particles (VLP) were used as antigen in a polymer enzyme-linked immunosorbent assay (ELISA) to measure antibodies to HPV capsid proteins. Serum samples from 575 college women, previously tested for the presence of cervicovaginal HPV DNA, were analyzed. The prevalences of anti-HPV16 VLP antibodies at baseline were 14.1{\%} for immunoglobulin G (IgG) and 6.4{\%} for IgA. The seroprevalences of IgG in women with cervicovaginal HPV16, HPV16-related types, and other HPV types were 55, 33, and 19{\%}, respectively (P < 0.001), compared to the prevalence in women without an HPV infection (10{\%}). HPV VLP IgA seropositivity was associated with high HPV16 VLP IgG optical density values. The seropositivity of IgG antibodies was independently associated with infection with HPV16 or HPV16-related types, increased number of lifetime male partners for vaginal sex, having sex with men ≥5 years older, history of abnormal PAP smear, older age, and living separately from parents. Use of HPV16 VLP polymer ELISA detects clade-specific responses and suggests an HPV16 VLP vaccine may have broader protection that initially anticipated.",
author = "Studentsov, {Yevgeniy Y.} and Ho, {Gloria Y F} and Marks, {Morgan A.} and Robert Bierman and Burk, {Robert D.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1128/JCM.41.7.2827-2834.2003",
language = "English (US)",
volume = "41",
pages = "2827--2834",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses

AU - Studentsov, Yevgeniy Y.

AU - Ho, Gloria Y F

AU - Marks, Morgan A.

AU - Bierman, Robert

AU - Burk, Robert D.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Human papillomavirus type 16 (HPV16) virus-like particles (VLP) were used as antigen in a polymer enzyme-linked immunosorbent assay (ELISA) to measure antibodies to HPV capsid proteins. Serum samples from 575 college women, previously tested for the presence of cervicovaginal HPV DNA, were analyzed. The prevalences of anti-HPV16 VLP antibodies at baseline were 14.1% for immunoglobulin G (IgG) and 6.4% for IgA. The seroprevalences of IgG in women with cervicovaginal HPV16, HPV16-related types, and other HPV types were 55, 33, and 19%, respectively (P < 0.001), compared to the prevalence in women without an HPV infection (10%). HPV VLP IgA seropositivity was associated with high HPV16 VLP IgG optical density values. The seropositivity of IgG antibodies was independently associated with infection with HPV16 or HPV16-related types, increased number of lifetime male partners for vaginal sex, having sex with men ≥5 years older, history of abnormal PAP smear, older age, and living separately from parents. Use of HPV16 VLP polymer ELISA detects clade-specific responses and suggests an HPV16 VLP vaccine may have broader protection that initially anticipated.

AB - Human papillomavirus type 16 (HPV16) virus-like particles (VLP) were used as antigen in a polymer enzyme-linked immunosorbent assay (ELISA) to measure antibodies to HPV capsid proteins. Serum samples from 575 college women, previously tested for the presence of cervicovaginal HPV DNA, were analyzed. The prevalences of anti-HPV16 VLP antibodies at baseline were 14.1% for immunoglobulin G (IgG) and 6.4% for IgA. The seroprevalences of IgG in women with cervicovaginal HPV16, HPV16-related types, and other HPV types were 55, 33, and 19%, respectively (P < 0.001), compared to the prevalence in women without an HPV infection (10%). HPV VLP IgA seropositivity was associated with high HPV16 VLP IgG optical density values. The seropositivity of IgG antibodies was independently associated with infection with HPV16 or HPV16-related types, increased number of lifetime male partners for vaginal sex, having sex with men ≥5 years older, history of abnormal PAP smear, older age, and living separately from parents. Use of HPV16 VLP polymer ELISA detects clade-specific responses and suggests an HPV16 VLP vaccine may have broader protection that initially anticipated.

UR - http://www.scopus.com/inward/record.url?scp=0038152717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038152717&partnerID=8YFLogxK

U2 - 10.1128/JCM.41.7.2827-2834.2003

DO - 10.1128/JCM.41.7.2827-2834.2003

M3 - Article

VL - 41

SP - 2827

EP - 2834

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 7

ER -